(Q40386096)

English

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

scientific article published on July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

immuno-oncology

1 reference

based on heuristic

inferred from title

Carsten Denkert

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Frederick Klauschen

37

object named as

Frederick Klauschen

0 references

Frédérique Penault-Llorca

24

object named as

Frederique Penault-Llorca

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Giuseppe Floris

object named as

Giuseppe Floris

16

0 references

Sunil R Lakhani

object named as

Sunil R Lakhani

23

0 references

object named as

Sherene Loi

43

0 references

object named as

Peter Sinn

30

0 references

Stefan Michiels

object named as

Stefan Michiels

42

0 references

Peter A. Fasching

39

object named as

Peter A Fasching

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

object named as

Sibylle Loibl

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

38

object named as

Michael Untch

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

33

object named as

Giuseppe Viale

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

11

object named as

Ewa Chmielik

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Stephan Wienert

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Audrey Poterie

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jan Budczies

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sunil Badve

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Zsuzsanna Bago-Horvath

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Anita Bane

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Shahinaz Bedri

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jane Brock

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Matthias Christgen

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Cecile Colpaert

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sandra Demaria

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gert Van den Eynden

15

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dongxia Gao

18

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Barbara Ingold Heppner

19

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

S Rim Kim

20

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Zuzana Kos

21

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hans H Kreipe

22

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Giancarlo Pruneri

25

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Nina Radosevic-Robin

26

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

David L Rimm

27

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Stuart J Schnitt

28

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Bruno V Sinn

29

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Nicolas Sirtaine

31

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sandra A O'Toole

32

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Koen Van de Vijver

34

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Roland de Wind

35

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gunter von Minckwitz

36

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Toralf Reimer

40

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Karen Willard-Gallo

41

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Roberto Salgado

44

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1155-1164

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2016.109

0 references

The immune contexture in human tumours: impact on clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Immune regulation of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

The immune system and response to HER2-targeted treatment in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

An international Ki67 reproducibility study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

An international study to increase concordance in Ki67 scoring

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.109

21 January 2018

Triple-negative breast cancer: immune modulation as the new treatment paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/27363491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27363491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MODPATHOL.2016.109

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40386096&oldid=1896725426"